Floatz logo

Arestin

Metabolic Syndrome

Central South UniversityDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
73/ 100

Competitive context

57 Active assets in the Metabolic Syndrome cohort.

Asset / SponsorPhaseRating
Lipitor
Seoul National University Hospital
Phase 4BBB
Metformin
Islamabad Medical and Dental College
Phase 4BBB
Pioglitazone
Philip Kern
Phase 4BBB
OLMESARTAN MEDOXOMIL
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Phase 4BBB
Rosuvastatin
Hamdard University
Phase 4BBB

View all 50 →

Same molecule, other indications

Arestin is also rated in:

mood disorderDormant
BBB
Indicative ·
73 / 100
View asset →
bipolar depressionDormant
BB
Indicative ·
70 / 100
View asset →
ischemic strokeDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →